U.S. FDA Approves Chemo Group's Benznidazole to Treat Children with Chagas Disease

WASHINGTON D.C., BUENOS AIRES, Argentina, MADRID and GENEVA, August 31, 2017 -- (Healthcare Sales & Marketing Network) -- On August 29th, the U.S. Food and Drug Administration (FDA) approved Chemo Research's New Drug Application (NDA) for benznidazole. Th... Biopharmaceuticals, FDA Chemo Group, benznidazole, Chagas disease

http://salesandmarketingnetwork.com/news_release_bs.html?ID=2042913

Source: HSMN NewsFeed - August 31, 2017 Category: Pharmaceuticals Source Type: news